These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2542566)

  • 1. Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound.
    Heinz BA; Rueckert RR; Shepard DA; Dutko FJ; McKinlay MA; Fancher M; Rossmann MG; Badger J; Smith TJ
    J Virol; 1989 Jun; 63(6):2476-85. PubMed ID: 2542566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural studies on human rhinovirus 14 drug-resistant compensation mutants.
    Hadfield AT; Oliveira MA; Kim KH; Minor I; Kremer MJ; Heinz BA; Shepard D; Pevear DC; Rueckert RR; Rossmann MG
    J Mol Biol; 1995 Oct; 253(1):61-73. PubMed ID: 7473717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14.
    Shepard DA; Heinz BA; Rueckert RR
    J Virol; 1993 Apr; 67(4):2245-54. PubMed ID: 8383239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WIN 52035-dependent human rhinovirus 16: assembly deficiency caused by mutations near the canyon surface.
    Wang W; Lee WM; Mosser AG; Rueckert RR
    J Virol; 1998 Feb; 72(2):1210-8. PubMed ID: 9445020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug.
    Otto MJ; Fox MP; Fancher MJ; Kuhrt MF; Diana GD; McKinlay MA
    Antimicrob Agents Chemother; 1985 Jun; 27(6):883-6. PubMed ID: 2992365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of drug-resistance mutants to identify functional regions in picornavirus capsid proteins.
    Mosser AG; Shepard DA; Rueckert RR
    Arch Virol Suppl; 1994; 9():111-9. PubMed ID: 8032243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of drug resistance mutations in type 3 poliovirus identifies three regions involved in uncoating functions.
    Mosser AG; Sgro JY; Rueckert RR
    J Virol; 1994 Dec; 68(12):8193-201. PubMed ID: 7966611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human rhinovirus 14 complexed with fragments of active antiviral compounds.
    Bibler-Muckelbauer JK; Kremer MJ; Rossmann MG; Diana GD; Dutko FJ; Pevear DC; McKinlay MA
    Virology; 1994 Jul; 202(1):360-9. PubMed ID: 8009848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug.
    Woods MG; Diana GD; Rogge MC; Otto MJ; Dutko FJ; McKinlay MA
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2069-74. PubMed ID: 2559655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug.
    Fox MP; Otto MJ; McKinlay MA
    Antimicrob Agents Chemother; 1986 Jul; 30(1):110-6. PubMed ID: 3019232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VP4 protein from human rhinovirus 14 is released by pressure and locked in the capsid by the antiviral compound WIN.
    Gonçalves RB; Mendes YS; Soares MR; Katpally U; Smith TJ; Silva JL; Oliveira AC
    J Mol Biol; 2007 Feb; 366(1):295-306. PubMed ID: 17161425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics simulations of human rhinovirus and an antiviral compound.
    Speelman B; Brooks BR; Post CB
    Biophys J; 2001 Jan; 80(1):121-9. PubMed ID: 11159387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel benzonitrile analogue inhibits rhinovirus replication.
    Lacroix C; Querol-Audí J; Roche M; Franco D; Froeyen M; Guerra P; Terme T; Vanelle P; Verdaguer N; Neyts J; Leyssen P
    J Antimicrob Chemother; 2014 Oct; 69(10):2723-32. PubMed ID: 24948704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating.
    Smith TJ; Kremer MJ; Luo M; Vriend G; Arnold E; Kamer G; Rossmann MG; McKinlay MA; Diana GD; Otto MJ
    Science; 1986 Sep; 233(4770):1286-93. PubMed ID: 3018924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional structures of drug-resistant mutants of human rhinovirus 14.
    Badger J; Krishnaswamy S; Kremer MJ; Oliveira MA; Rossmann MG; Heinz BA; Rueckert RR; Dutko FJ; McKinlay MA
    J Mol Biol; 1989 May; 207(1):163-74. PubMed ID: 2544734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding affinities of structurally related human rhinovirus capsid-binding compounds are related to their activities against human rhinovirus type 14.
    Fox MP; McKinlay MA; Diana GD; Dutko FJ
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1040-7. PubMed ID: 1656851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site.
    Wald J; Pasin M; Richter M; Walther C; Mathai N; Kirchmair J; Makarov VA; Goessweiner-Mohr N; Marlovits TC; Zanella I; Real-Hohn A; Verdaguer N; Blaas D; Schmidtke M
    Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19109-19115. PubMed ID: 31462495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses.
    Badger J; Minor I; Oliveira MA; Smith TJ; Rossmann MG
    Proteins; 1989; 6(1):1-19. PubMed ID: 2558377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors.
    Pevear DC; Fancher MJ; Felock PJ; Rossmann MG; Miller MS; Diana G; Treasurywala AM; McKinlay MA; Dutko FJ
    J Virol; 1989 May; 63(5):2002-7. PubMed ID: 2539499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pocket factors are unlikely to play a major role in the life cycle of human rhinovirus.
    Katpally U; Smith TJ
    J Virol; 2007 Jun; 81(12):6307-15. PubMed ID: 17428846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.